In this section: Research

Overfield series · Part 1 of 3 · 4 November 2026

CFMG Won a Discovery Order. That Is Not a Ruling on Who Controls Its Physicians.

A federal court’s decision to limit financial discovery in Overfield leaves a different question unanswered: whether the management arrangements preserve the authority California reserves to licensed physicians

The October 30 order is a clean defense win, and it should be reported as one. It is also a precise ruling about one question in one case. This article explains what that question was, why the court was entitled to answer it narrowly, and why the answer does not reach California’s fee-splitting and corporate-practice law. Every proposition is graded; the evidence ledger is in the 4 November court-record update.

  • Published 4 Nov 2026
  • Record through ECF 96 (30 Oct 2026)
  • Read ECF 95 joint statement (public, redacted)
  • Not inspected deposition transcript
  • Series Part 2 · Part 3

Begin with the win

Court disposition On 30 October 2026 the magistrate judge in Overfield granted California Forensic Medical Group’s motion for a protective order. Plaintiffs had sought information about the management-services fees CFMG pays Wellpath LLC so their financial expert could assess, in plaintiffs’ framing, whether the arrangement was commensurate with the value of the services under Business and Professions Code § 650. The court said no.V01

Court’s account The reason was specific. CFMG’s finances matter in this case because plaintiffs seek punitive damages, and a defendant’s financial condition bears on those. A year earlier the same judge had held that CFMG’s consolidated GAAP-audited financial statements, tax returns and other records were enough for that purpose, and that receipts for management fees would offer only a tenuous basis for conjecture. The October order applied that ruling: the court had already held that Wellpath–CFMG financial dealings are not relevant to the punitive-damages issue, and plaintiffs already had what they needed to measure CFMG’s current condition.V01V02

That is the starting point. It is not a reason to minimise the defense victory, and it is not a licence to convert the losing side’s arguments into facts. It is a reason to be exact about what was decided — because the order and the parties’ joint statement behind it contain the first public framing in this investigation’s record of a statutory fee-value question and an asserted cash-movement mechanism between CFMG and Wellpath — in plaintiffs’ words, as advocacy.V01V09

The proposition

A court’s determination that a medical corporation has produced enough financial information for a punitive-damages inquiry is not a determination that its management fees, its money movements, or its allocation of professional authority comply with California law. Those are different questions, and the court was not asked to answer them.

What each side told the court

Defense position The parties’ joint statement, ECF 95, shows how narrowly CFMG framed the dispute — and how far plaintiffs tried to widen it. CFMG’s counsel told the court that CFMG had produced five years of tax returns and an unredacted management services agreement that “includes the monthly payment percentage” paid to Wellpath LLC; that the request was a “backdoor” into the finances of discharged, non-party Wellpath; that plaintiffs “have no claims relating to the fair market value of Wellpath’s management services and do not have standing to bring any such claims”; and that § 650 itself creates no civil cause of action. The defense also cited a 21 April 2026 order in Smith v. California Forensic Medical Group (N.D. Cal.), which it describes as refusing to compel CFMG–Wellpath management agreements and related testimony.V09

Plaintiffs’ position Plaintiffs answered with their account of the deposition of CFMG’s financial designee: an 18 percent gross-revenue fee, booked as an expense but — in plaintiffs’ telling of the testimony — not consistently paid in cash; “cash sweeps” whose amounts and timing the witness could not explain; and a witness who did not know what the services cost or think their value could be estimated. Their argument was that without knowing what CFMG actually pays, no one can tell whether it runs at a profit or a loss.V09

Analysis Both framings are advocacy. Neither is a finding, and the court adopted neither on the merits. What the exchange does show is that the § 650 question was squarely raised and expressly set aside as outside the punitive-damages inquiry — which is exactly why the order cannot be read as resolving it. Part 2 examines plaintiffs’ account line by line.

1. Three questions, not one

Analysis Three inquiries can draw on some of the same documents without being the same inquiry.

InquiryWhat it asksWhere it was answered
Ability to payWhat financial evidence is needed to assess a defendant’s condition for punitive damages?Answered for this case: what CFMG produced is enough (ECF 72; ECF 96).
Management-fee valueWhat did the compensation buy, from whom, and is it commensurate with the services or fair rental value (§ 650(b))?Not answered. The court declined the discovery as irrelevant to punitive damages; it made no § 650 finding.
Professional controlWho exercises — or holds the enforceable right to exercise — decisions California reserves to licensed physicians?Not answered, and not before the court.

Consider an expressly hypothetical arrangement — not a description of CFMG. A medical corporation pays a management company a commercially supported fee for accounting, information systems and administrative staff. The fee may be lawful even if it is large. Yet a separate clause giving the manager final authority over protected treatment decisions would raise a different problem entirely. Conversely, an expensive contract a physician-owner regrets is not, by that fact, evidence that the manager practises medicine. A financial statement cannot answer every governance question, and a governance question cannot establish financial misconduct.

2. What the federal ruling means — and does not

Legal rule Federal discovery reaches nonprivileged matter relevant to a party’s claim or defense and proportional to the needs of the case. Courts must limit discovery that is unreasonably cumulative or outside that scope, and may issue protective orders for good cause. The October order applied exactly those rules, citing Rule 26(c) and Seattle Times Co. v. Rhinehart for the court’s broad discretion over protective orders.V06V10V01

Analysis Two overstatements must be avoided. The first is that the ruling shows corporate-practice or fee-splitting questions never belong in federal court. That is wrong: a properly pleaded, jurisdictionally supported case may present them, and supplemental jurisdiction has its own statutory framework. The point is narrower — this inquiry was not warranted for the financial issue in this case on this record.V08 The second overstatement runs the other way: that the order approved the arrangement. It did not examine the management agreement, value any service, or allocate any authority. Plaintiffs cannot treat a regulatory concern as permission to disregard the order; defendants cannot treat the order as a declaration that every provision of an unexamined agreement complies with state professional law.

3. The California question is authority

Legal rule California’s Medical Practice Act makes practising medicine without a licence a public offense (Bus. & Prof. Code § 2052) and provides that corporations and other artificial entities “shall have no professional rights, privileges, or powers” (§ 2400). The Medical Board’s guidance identifies decisions that must be made by a California-licensed physician: what diagnostic tests are appropriate, the need for referrals, responsibility for the patient’s overall care, and how many patients a physician must see or how many hours a physician must work. It adds “business” or “management” decisions that result in control over the practice — ownership and content of medical records; selection and hiring or firing of clinical staff as it relates to clinical competency or proficiency; the parameters of payer contracts; coding and billing decisions; and approval of medical equipment and supplies. These, the Board says, cannot be delegated to unlicensed persons, “including (for example) management service organizations.” A physician may consult unlicensed persons but must retain ultimate responsibility for, or approval of, those decisions.V16

Legal rule The inquiry must also respect lawful management. In Epic Medical Management, LLC v. Paquette (2015) 244 Cal.App.4th 504, the Court of Appeal affirmed a judgment confirming an arbitration award for a management company. It held the illegality issue unreviewable in that posture and added that, if it were reviewable, the contract was “not illegal as a matter of law.” It explained that whether a physician–manager relationship crosses into unlicensed practice requires interpreting the agreement’s substantive provisions, and “turns on whether the non-licensee exercises or has retained the right to exercise control or discretion over the physician’s practice.”V17

Analysis That sentence corrects an investigative error in both directions. A documented instruction to withhold a particular treatment would be powerful evidence — but the absence of such an instruction does not validate a contract that allocates prohibited authority, because retaining the right to control is itself part of the test. Equally, financial dependence alone does not establish that any prohibited right exists. The publication’s task is to identify the right, the entity holding it, the professional decision it reaches, and any lawful exception or administrative explanation.

4. Form is not the entire inquiry

Legal rule In People ex rel. Allstate Ins. Co. v. Discovery Radiology Physicians, P.C. (2023) 94 Cal.App.5th 521, the Court of Appeal reversed judgments entered after demurrers and reinstated insurance-fraud and unfair-competition complaints alleging that physician-owned corporations were in substance controlled by non-physicians. The court explained that a non-licensee need not examine a patient to practise medicine unlawfully; undue control can be exercised by owning a practice or by choosing physicians, selecting equipment, setting the parameters of physicians’ employment, or making billing decisions.V18

Analysis The posture limits the use. Discovery Radiology held that the complaints adequately pleaded those theories; it made no trial findings against those defendants, and none about CFMG or Wellpath. Its relevance is analytical: nominal physician ownership does not end the examination of actual or retained control. The point cuts both ways. Shared branding, a common administrative workforce or consolidated reporting is not proof that a professional corporation is fictitious. But a professional corporation’s existence is not a substitute for asking who holds its protected powers.

5. The 2026 statute is a check, not a shortcut

Legal rule SB 351, signed on 6 October 2025, added Health and Safety Code §§ 1190–1192, operative 1 January 2026. Section 1191 bars a “private equity group or hedge fund” involved with a California physician or dental practice from interfering with physicians’ professional judgment in listed decisions, and from exercising control over — or being delegated — listed functions: medical-record content, hiring and firing based on clinical competency, payer-contract parameters, coding and billing, and equipment approval. Contract terms that violate those limits are “void, unenforceable, and against public policy”; the Attorney General may seek injunctive relief and fees. Section 1191(g) states that the section does not narrow the existing corporate-practice bar, and § 1191(h) preserves consultation where the physician retains ultimate responsibility or approval.V22V19

Analysis Three checks come before any application to a Wellpath-related entity: whether the actor meets § 1190’s definitions of a private equity group or hedge fund and none of its exclusions; which instrument and which conduct are at issue; and whether that conduct post-dates 1 January 2026. Historical sponsorship is not current ownership, and a statute effective in 2026 does not govern earlier conduct without a valid temporal analysis. The older Medical Practice Act applies independently of whether § 1191 does.V21

6. Where the financial questions lead — and where they stop

Analysis The Overfield orders supply an identifiable place to begin asking about service compensation and intercompany transfers. They do not supply a public transaction-level reconstruction or the operative governance instruments. According to CFMG’s representation recorded in ECF 72, annual management-fee totals appear in tax returns produced in discovery; those returns are not public, and nothing in this series estimates them.V02

A rigorous inquiry would obtain lawful access to documents showing how compensation is calculated; how each relevant transfer is classified; who may initiate, approve or reverse it; what rights the medical corporation has to retain funds for its own obligations; and who decides disputes over protected professional choices. The strongest evidence would connect a specific financial or contractual power to a physician-reserved decision — an instrument authorising a non-licensee to override a protected decision would be far more probative than any general claim that finance influences medicine. That is a hypothetical comparison, not a clause established in CFMG’s contracts.

The same inquiry must be able to clear the companies. Independent physician approval, transparent accounting, a supportable fee valuation, enforceable reserved powers and a workable right to change managers would each materially weaken a theory of prohibited control. Part 2 sets out those tests in detail.

7. A regulatory referral is not a second discovery motion

Legal rule Public enforcement has its own gates. Section 656 allows a superior court to enjoin violations of the article containing § 650 on application of specified boards — including the Medical Board and the Osteopathic Medical Board — the Attorney General, or the county district attorney. Section 2311 allows an injunction against Medical Practice Act offenses on application of the Board or of ten or more licensed physicians or podiatrists. Private standing under the Unfair Competition Law requires a person who “has suffered injury in fact and has lost money or property” (§ 17204). None of these turns an observer into a private prosecutor. CFMG’s own position in ECF 95 points the same way: it argues that a § 650 violation can lead to criminal prosecution, fines or licensing discipline but not a private civil claim. Whatever the merits of that position in other contexts, it confirms that the fee question belongs, if anywhere, to public enforcers and licensing boards rather than to punitive-damages discovery.V12V13V14V09

Analysis A responsible referral would identify the public orders and ask whether particular management powers warrant examination. It would not say the judge found unlawful cash extraction, that any company committed fee-splitting, or that any physician acted improperly, because those findings do not exist. Nor may publication be used to circulate protected discovery. The court-approved protective order in this case requires a written order before anything designated confidential — transcripts included — is filed under seal, and California’s fair-report privilege does not protect a publication that breaches a court order or a legally imposed confidentiality requirement.V05V15V10

Court’s account Bankruptcy is a further, separate constraint. The court records that the Wellpath Chapter 11 discharged claims against the debtor entities, including Wellpath LLC, and enjoined pursuit of prepetition claims against them. Attaching a regulatory label to a private damages claim does not escape a discharge; the actor, the debt, the date of the conduct and the remedy sought each matter.V01V24

8. The strongest defense reading, at full strength

CFMG would say — with force — that it won twice on the same point; that California expressly permits revenue-based management compensation; that consolidated audited financials are ordinary for an affiliated group; that plaintiffs repeatedly sought Wellpath’s records through CFMG after Wellpath’s discharge; and that a cash-management practice described by a witness in a deposition is not evidence of anything improper without the accounting that explains it. Each of those points is either established by the orders or legally correct, and each is reported here at its true weight.V01V02V11

Analysis The response is not to dispute them reflexively. It is to accept them and insist on the different, document-specific question they do not reach: what powers the operative arrangements confer, who holds those powers, and whether they reach decisions California reserves to licensed professionals.

What would change this analysis

  • The Lukasik transcript showing that “not documented” meant only that the witness lacked personal knowledge, or that the transfers were ordinary, reconciled fee settlements under a written treasury arrangement. That would narrow Part 2’s questions sharply.
  • A later order reopening or modifying the financial discovery, or a merits ruling touching the management relationship.
  • Operative instruments showing CFMG’s physicians hold final, enforceable authority over every physician-reserved decision and a workable right to replace the manager — evidence that would answer the control question in CFMG’s favour.

The question left open

The meaningful public question is not whether CFMG should have lost its discovery motion. It is whether the professional corporation’s licensed decision-makers retain the authority the law requires them to retain. A damages ruling can settle the adequacy of financial discovery without settling that question. The next stage of reporting must move from insinuation to instruments: the governing agreements, the delegated powers, the financial authorisations and the legally protected limits.

CFMG’s discovery victory should be reported accurately. The professional-control question should be investigated on its own legal and evidentiary terms.

Continue: Part 2 — fees and alleged cash sweeps · Part 3 — who can say no · the evidence ledger · the CPOM enforcement record

Source register

  1. V01Overfield v. County of El Dorado et al. (caption as in the order), No. 2:24-cv-0199 TLN AC (E.D. Cal.), ECF 96 — order granting CFMG’s motion for a protective orderSigned order dated 2026-10-30 · public reproduction (Justia), 4 pp. · read in full 2026-11-04 · pp. 2–4 cited · cites ECF 95 at 2 and 13 (not inspected)
  2. V02Overfield v. Wellpath Community Care, LLC et al., ECF 72 — order denying plaintiffs’ motion to compel (ECF 69)Signed order dated 2025-09-23 · public reproduction, 5 pp. · read in full 2026-11-04 · pp. 2–5 cited
  3. V05Overfield, ECF 33 — protective order approving the parties’ Stipulated Protective Order (ECF 31)Signed order dated 2024-05-09 · public reproduction, 2 pp. · read in full 2026-11-04 · ECF 31 terms not inspected
  4. V06Federal Rule of Civil Procedure 26 — (b)(1), (b)(2)(C), (c)Rule text, public reproduction (Cornell LII) · applied in ECF 87 and ECF 96
  5. V0828 U.S.C. § 1367 — supplemental jurisdictionStatute, public reproduction (Cornell LII)
  6. V09Overfield, ECF 95 — Joint Discovery Statement re: Discovery Dispute (public redacted filing)Filed 2026-10-26; signed by counsel 2026-10-07 · 15 pp., read in full 2026-11-04 from CM/ECF (PACER account required) · defense position pp. 2–11; plaintiffs’ position pp. 11–14 · Exhibits A–C not inspected · party advocacy, not findings
  7. V10Seattle Times Co. v. Rhinehart, 467 U.S. 20 (1984)U.S. Supreme Court · protective orders limiting dissemination of pretrial discovery · cited in ECF 96 at p. 4
  8. V11California Business and Professions Code § 650 — (a) referral compensation; (b) percentage-based compensation for non-referral servicesStatute, public reproduction · text checked 2026-11-04 against the reproduction (reports verification against leginfo, 2 Nov 2026) · official text: leginfo.legislature.ca.gov
  9. V12California Business and Professions Code § 656 — injunctions; specified public applicantsStatute, public reproduction · checked 2026-11-04
  10. V13California Business and Professions Code § 2311 — Medical Practice Act injunctions; the board or 10 or more licenseesStatute, public reproduction · checked 2026-11-04
  11. V14California Business and Professions Code § 17204 — UCL standingStatute, public reproduction · checked 2026-11-04
  12. V15California Civil Code § 47(d) — fair and true report; exceptions for breach of a court order or legally imposed confidentialityStatute, public reproduction · checked 2026-11-04
  13. V16Medical Board of California — Practice Information: Corporate Practice of Medicine (Bus. & Prof. Code §§ 2052, 2400)Official regulatory guidance · read 2026-11-04 · not an adjudication against any company
  14. V17Epic Medical Management, LLC v. Paquette (2015) 244 Cal.App.4th 504 (No. B261541)Published opinion, Second District, Division Eight · filed 2015-12-29; publication ordered 2016-01-28 · official PDF read 2026-11-04 · arbitration-confirmation posture; judgment for the management company affirmed
  15. V18People ex rel. Allstate Ins. Co. v. Discovery Radiology Physicians, P.C. (2023) 94 Cal.App.5th 521 (No. B315264)Published opinion, Second District, Division Three · filed 2023-08-15 · official PDF read 2026-11-04 · reversal of dismissals after demurrer; pleading-stage, no trial findings
  16. V19California Attorney General, amicus curiae brief in support of neither party, Art Center Holdings, Inc. v. WCE CA Art, LLC, No. B338625 (Cal. Ct. App., 2d Dist., Div. 3)Official litigation position dated 2026-03-30 · read 2026-11-04 · cited pp. 10, 14–17, 21–22, 24–30 · not appellate precedent; no decision located on 2026-11-04
  17. V21California Health and Safety Code § 1190 — definitions of “hedge fund” and “private equity group,” with exclusionsStatute added by SB 351 (Stats. 2025, ch. 409) · public reproduction checked 2026-11-04
  18. V22California Health and Safety Code § 1191 — private equity and hedge-fund restrictions; (c) void terms; (d) non-compete and non-disparagement; (e) Attorney General enforcement; (g)–(h)Statute added by SB 351, signed 2025-10-06 · operative 2026-01-01 · public reproduction checked 2026-11-04
  19. V2411 U.S.C. §§ 362(b)(4) and 524 — police-and-regulatory exception to the stay; effect of dischargeStatute, public reproduction (Cornell LII) · operative bankruptcy orders control their own scope

Kanwar Partap Singh Gill, MD
Family Medicine Physician · Fresno, California, USA

Original KPSGILL documentary investigation · court dispositions, the court’s account of the record, party assertions and analytical inferences distinguished throughout · never official-government data · record current through ECF 96 (30 October 2026) · sources checked 4 November 2026, as marked in the register · Prepared and published 4 November 2026 by Kanwar Partap Singh Gill, MD · .

Search KPSGill.com

Search the full publication — patient guides, policy, investigations, enforcement records and research.